Neoral and Thirst - excessive - a phase IV clinical study of FDA data

Summary:

Thirst - excessive is reported as a side effect among people who take Neoral (cyclosporine), especially for people who are male, 30-39 old, have been taking the drug for < 1 month also take Humira, and have Anaemia vitamin b12 deficiency.

The phase IV clinical study analyzes which people have Thirst - excessive when taking Neoral. It is created by eHealthMe based on reports of 25,970 people who have side effects when taking Neoral from the FDA, and is updated regularly.

What is Neoral?

Neoral has active ingredients of cyclosporine. It is often used in psoriasis. eHealthMe is studying from 26,084 Neoral users. Check the latest studies of Neoral.

What is Thirst - excessive?

Thirst - excessive is found to be associated with 553 drugs and 1,010 conditions by eHealthMe. Check the latest studies of Thirst - excessive.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

25,970 people reported to have side effects when taking Neoral.
Among them, 72 people (0.28%) have Thirst - excessive.

Among these 72 people:

How long have people been on Neoral when they have Thirst - excessive? *

What is the gender of people who have Thirst - excessive when taking Neoral? *

female: 15.71 %
male: 84.29 %

What is the age of people who have Thirst - excessive when taking Neoral? *

What are other drugs people take besides Neoral? *

What are other side effects people have besides Thirst - excessive? *

Drug Ineffective: 55 people, 76.39%
Pneumonia: 55 people, 76.39%
Muscle Spasms (muscle contraction): 52 people, 72.22%
Pain In Extremity: 52 people, 72.22%
Nosebleed (bleeding from nose): 52 people, 72.22%
Drug Eruption (adverse drug reaction of the skin): 52 people, 72.22%
Hepatic Function Abnormal: 52 people, 72.22%
Hypersensitivity: 52 people, 72.22%
Urticaria (rash of round, red welts on the skin that itch intensely): 52 people, 72.22%
Stomatitis (inflammation of mucous membrane of mouth): 45 people, 62.50%

What are the existing conditions these people have? *

Mucosal Haemorrhage (bleeding from mucous membrane): 4 people, 5.56%
Gastric Ulcer (stomach ulcer): 4 people, 5.56%
Aplasia Pure Red Cell (type of anaemia affecting the precursors to red blood cells but not to white blood cells): 4 people, 5.56%
Anaemia Vitamin B12 Deficiency: 4 people, 5.56%
Drug Exposure During Pregnancy: 3 people, 4.17%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 2.78%
Pneumocystis Jiroveci Pneumonia (fungal infection of the lungs): 2 people, 2.78%
Pain: 1 person, 1.39%
Myasthenia Gravis (a chronic condition that causes muscles to tire and weaken easily): 1 person, 1.39%
Aplastic Anemia: 1 person, 1.39%

* Approximation only. Some reports may have incomplete information.

Do you take Neoral and have Thirst - excessive?

- Check whether Thirst - excessive is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Neoral:

Neoral (26,084 reports)

Browse all side effects of Neoral:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Thirst - excessive:

Thirst - excessive (553 drugs)

Browse all the conditions that are associated with Thirst - excessive:

Thirst - excessive (1,010 conditions)

Related publications that referenced our studies

O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on cyclosporine (the active ingredients of Neoral) and Neoral (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.